Private sector working to ensure it doesn’t get worse before it gets better
The Orange County Register | Sally C. Pipes and Henry Miller, M.S., M.D.
April 1, 2020
The statistics are grim. In less than three months, the virus has surged from Wuhan, China, to infect more than 750,000 people across 203 countries, areas, and territories. As of March 31, the death toll is over 36,000, including over 2,800 in the U.S., and the number of infections is currently accelerating in New York City, Atlanta, New Orleans, and San Francisco. Government officials’ mantra: “It will get worse before it gets better.” |
|
|
|
Now an Amazon.com #1 bestseller among policy books (health law books).
|
|
Telehealth should stay long after COVID-19 goes
The Deseret News | Sally C. Pipes
April 6, 2020
It may have taken a public health emergency to bring “telehealth” to the mainstream, but these services are nothing new. We would do well to expand our reliance on telehealth long after COVID-19 is behind us. Telehealth involves the use of technology to deliver medical care from a distance.
Read more. . .
|
|
The Medicare Bureaucracy Is Unnecessarily Putting Kidney Patients At Risk
Forbes | Wayne Winegarden
April 6, 2020
In light of this guidance, the Centers for Medicare & Medicaid Services’ (CMS) decision not to cover an FDA-approved, at-home medicine for patients with chronic kidney disease (CKD) is irresponsible. With most Americans ordered to shelter-in-place, vulnerable kidney patients shouldn’t be forced into crowded hospitals for several hours of infusions when they could be taking an oral alternative in the safety and comfort of their own homes.
|
|
Dr. Henry Miller and John Batchelor Explain Coronavirus Antibody Testing
The John Batchelor Show | Henry Miller, M.S., M.D.
April 2, 2020
Dr. Henry Miller joins the John Batchelor Show for his weekly discussion on the coronavirus pandemic and the latest developments about COVID-19. Dr. Miller and John Batchelor debate the benefits of serology, or antibody testing, from patients with diagnosed or suspected of having the novel coronavirus and the different rates of infection. |
|
Optimism About a Speedy Coronavirus Vaccine Is Misplaced
The Bridge | Henry Miller, M.S., M.D.
April 5, 2020
Clearly there is deep interest and a sense of urgency in all quarters. So what’s standing in the way of the rapid deployment of a vaccine? For one, there are potential safety issues, particularly with new technologies, as are being used by COVID-19 vaccine makers.
Read more. . .
|
|
|
|
New Animated Series Aims to Help Patients “Escape the Drug Pricing Maze”
As prescription drug pricing and accessibility has become a greater topic of discussion during the current coronavirus pandemic, a new series of animated videos launched recently by the Center for Medical Economics and Innovation at the Pacific Research Institute aims to guide Americans through the “drug pricing maze”.
The new series will educate viewers on how the current drug pricing system is fueled by misguided policies that drive up costs, and how free-market reforms would steer us toward lower prices and more innovation.
|
|
|
|
